MTBP and hepatocellular carcinoma: The knockdown of MTBP in MHCC97-H cells accelerated the elimination of sorafenib in HCC cells or the subcutaneous tumor tissues, and the half-life time (t1/2 values) of sorafenib in HCC cells or tumor tissues was significantly reduced.